Source

Format

License

32570 results

NA
json

An open-label trial with TMC278 25 mg qd in combination with a background regimen containing 2 nucleosidenucleotide reverse transcriptase inhibitors in HIV-1 infected subjects who participated in TMC278 clinical trials

roll-over trial for continued TMC278 access
json

A phase III single group open study to assess the immunogenicity safety and reactogenicity of GlaxoSmithKline GSK Biologicals 10-valent pneumococcal conjugate vaccine in Taiwan when co-administered with GSK Biologicals Infanrix hexa DTPa-HBV-IPVHib vaccine as a 3-dose primary immunization course at 15 3 and 6 months of age and GSK Biologicals Rotarix vaccine HRV as a 2-dose primary immunization course at 15 and 3 months of age

Primary vaccination course in children receiving the pneumococcal vaccine GSK 1024850A Infanrix hexa and Rotarix
json

A PHASE III MULTICENTER RANDOMIZED PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB ANTIPD-L1 ANTIBODY IN COMBINATION WITH NAB-PACLITAXEL COMPARED WITH PLACEBO WITH NAB-PACLITAXEL FOR PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC TRIPLE-NEGATIVE BREAST CANCER

A trial of MPDL3280A and nab-Paclitaxel in metastatic triple negative breast cancer
json

A multicenter randomized double-blind placebo controlled Phase III study of the efficacy of xaliproden in preventing the neurotoxicity of oxaliplatin in first-line treatment of patients with metastatic colorectal cancer treated with oxaliplatin5-FULV

json